Empirical Finance »

Adaptimmune Therapeutics shares owned by Empirical Finance

Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Empirical Finance from 13F filings

Historical chart of Empirical Finance investment in Adaptimmune Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adaptimmune Therapeutics held by Empirical Finance consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptimmune Therapeutics by Empirical Finance

Quarter filed Position value Share count Share price at filing
2025-09-30 $104k 800k 0.13
2025-06-30 $192k 800k 0.24